HomeCompareLSVAX vs CL

LSVAX vs CL: Dividend Comparison 2026

LSVAX yields 20.52% · CL yields 2.43%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LSVAX wins by $34.6K in total portfolio value
10 years
LSVAX
LSVAX
● Live price
20.52%
Share price
$16.65
Annual div
$3.42
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$75.4K
Annual income
$7,119.09
Full LSVAX calculator →
CL
CL
● Live price
2.43%
Share price
$85.73
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.8K
Annual income
$5,401.96
Full CL calculator →

Portfolio growth — LSVAX vs CL

📍 LSVAX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLSVAXCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LSVAX + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LSVAX pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LSVAX
Annual income on $10K today (after 15% tax)
$1,744.01/yr
After 10yr DRIP, annual income (after tax)
$6,051.23/yr
CL
Annual income on $10K today (after 15% tax)
$206.23/yr
After 10yr DRIP, annual income (after tax)
$4,591.67/yr
At 15% tax rate, LSVAX beats the other by $1,459.56/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LSVAX + CL for your $10,000?

LSVAX: 50%CL: 50%
100% CL50/50100% LSVAX
Portfolio after 10yr
$58.1K
Annual income
$6,260.52/yr
Blended yield
10.78%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

LSVAX
No analyst data
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+7.8% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LSVAX buys
0
CL buys
0
No recent congressional trades found for LSVAX or CL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLSVAXCL
Forward yield20.52%2.43%
Annual dividend / share$3.42$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28.6%
Portfolio after 10y$75.4K$40.8K
Annual income after 10y$7,119.09$5,401.96
Total dividends collected$43.4K$18.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: LSVAX vs CL ($10,000, DRIP)

YearLSVAX PortfolioLSVAX Income/yrCL PortfolioCL Income/yrGap
1← crossover$12,752$2,051.77$11,012$312.01+$1.7KLSVAX
2$16,090$2,445.21$12,196$412.95+$3.9KLSVAX
3$20,099$2,883.41$13,599$549.66+$6.5KLSVAX
4$24,873$3,366.34$15,288$736.64+$9.6KLSVAX
5$30,507$3,893.27$17,353$995.28+$13.2KLSVAX
6$37,105$4,462.81$19,926$1,357.80+$17.2KLSVAX
7$44,776$5,072.96$23,194$1,873.82+$21.6KLSVAX
8$53,631$5,721.15$27,439$2,621.52+$26.2KLSVAX
9$63,790$6,404.35$33,088$3,727.38+$30.7KLSVAX
10$75,374$7,119.09$40,806$5,401.96+$34.6KLSVAX

LSVAX vs CL: Complete Analysis 2026

LSVAXStock

The fund normally will invest at least 80% of its net assets (plus any borrowings made for investment purposes) in the equity securities of small-cap companies, including preferred stocks, warrants, securities convertible into common or preferred stocks and other equity-like interests in an entity. Currently, the manager defines a small-cap company to be one whose market capitalization falls within the capitalization range of the Russell 2000® Index, an index that tracks stocks of 2,000 of the smallest U.S. companies.

Full LSVAX Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this LSVAX vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LSVAX vs SCHDLSVAX vs JEPILSVAX vs OLSVAX vs KOLSVAX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.